A novel cyclic AMP response element-binding protein-1 (CREB-1) splice product may down-regulate CREB-1 activity

Area of Science:

• Molecular Biology
• Gene Expression Regulation
• Cell Signaling

Background:

• Cyclic AMP (cAMP) response element-binding protein-1 (CREB-1) is a key transcription factor regulating gene expression in response to cAMP.
• Understanding CREB-1 regulation is crucial for deciphering cellular responses to various stimuli.
• Alternative splicing is a major mechanism for generating protein diversity and regulating gene function.

Purpose of the Study:

• To identify and characterize novel spliced variants of CREB-1 mRNA.
• To investigate the functional implications of these novel variants on CREB-1 protein and cAMP signaling.

Main Methods:

• Analysis of CREB-1 mRNA sequences to identify novel splice junctions.
• RT-PCR and sequencing to confirm the presence and structure of new mRNA forms.
• Quantitative analysis of mRNA abundance in different tissue types.

Main Results:

• Identification of novel CREB-1 mRNA spliced forms containing a 17-nucleotide "beta exon" insert.
• The beta exon inclusion shifts the reading frame, leading to premature termination of CREB-1 protein synthesis before the cAMP-dependent phosphorylation site.
• These beta exon-containing CREB-1 mRNAs are more prevalent in tissues exhibiting diminished cAMP responsiveness.

Conclusions:

• The novel beta exon inclusion in CREB-1 mRNA represents a previously unrecognized mechanism of post-transcriptional regulation.
• This alternative splicing event likely contributes to the down-regulation of CREB-1 activity and impaired cAMP signaling in specific tissues.
• These findings offer new insights into the complex regulation of CREB-1 and its role in cellular cAMP responsiveness.